Dosing Schedule For Solvay’s Pulzium Will Be Addressed During Cardio-Renal Meeting

FDA’s Cardiovascular and Renal Drugs Advisory Committee also will weigh whether tedisamil should be approved with risk management plan proposed by Solvay.